SOURCE-LINKED STUDY SUMMARY
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
Abstract summarizedQuality not appraised
- What was studied
- A retrospective matched cohort assessed whether prescribed semaglutide was associated with nonarteritic anterior ischemic optic neuropathy.
- Who / model studied
- Patients evaluated by neuro-ophthalmologists at one academic institution were analyzed separately for type 2 diabetes and overweight or obesity.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- Semaglutide prescriptions were associated with higher NAION risk in both clinical groups compared with non-GLP-1 medications.
- Limitations & context
- The observational single-institution design cannot establish causality, and the authors called for further study.
Read summary source ↗ · Prepared 9/16/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1001/jamaophthalmol.2024.2296